NCT02140281 - To Assess the Effect of AZD1722 on the Pharmacokinetics of Cefadroxil in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

Treatment A (cefadroxil alone)

A single 500 mg oral dose of cefadroxil will be given on the morning of Day 1

DRUG

Treatment B - AZD1722 followed by cefadroxil

15mg oral dose of AZD1722 will be given twice daily from Day 1 to Day 4 followed on the morning of Day 5 by a single dose of 15 mg AZD1722 taken together with a single 500mg dose of cefadroxil

Trial Locations (1)

Unknown

Research Site, Overland Park